In Investigating Pharmaceutical Distribution, Persistence and - - PowerPoint PPT Presentation

in investigating pharmaceutical distribution persistence
SMART_READER_LITE
LIVE PREVIEW

In Investigating Pharmaceutical Distribution, Persistence and - - PowerPoint PPT Presentation

In Investigating Pharmaceutical Distribution, Persistence and Degradation in Scottish Waters Lydia Niemi PhD Researcher and Hydro Nation Scholar Environmental Research Institute, University of the Highlands and Islands Contact:


slide-1
SLIDE 1

In Investigating Pharmaceutical Distribution, Persistence and Degradation in Scottish Waters

Lydia Niemi

PhD Researcher and Hydro Nation Scholar Environmental Research Institute, University of the Highlands and Islands Contact: lydia.niemi@uhi.ac.uk @LydiaNiemi

slide-2
SLIDE 2

Pharmaceuticals: ‘Emerging’ Environmental Contaminants

Comber et al. 2018; Information Services Division, 2016; Poirier-Larabie et al. 2016

Wastewater Treatment Surface Water Point Source

  • Pharma extensively used: >102 mil prescriptions in Scotland (2015 – 2016)
  • Entering environment mainly through inadequate wastewater treatment

Degradation?

Cl/H2O2 bio/hⱱ ?

?

hⱱ

Environmental Effects? Removal?

2

slide-3
SLIDE 3
  • 1. Develop analytical methods
  • 2. Pharmaceutical monitoring

(rural & urban)

  • 3. Degradation studies

To investigate pharmaceutical distribution, persistence and degradation in wastewater and effluent-receiving surface water

My Research Aims... ..

3

slide-4
SLIDE 4
  • Hospital wastewater & WWTP sampling

Current Work.. ... .

Changes in water quality, pharma introduction

Potable Water WWTP

Water quality changes from source to final effluent

  • Pharma degradation in lab-scale studies
  • Active & passive sampling in River

Dee

4

Sampling point WWTP DWTW SEPA gauging site

Hospital

slide-5
SLIDE 5

Results and Significance

5

Conc (ng/L) Hospital WW WW Influent Primary Effluent Paracetamol 1380 ± 450 3790 ± 1030 4030 ± 420 Ibuprofen 2070 ± 1920 3180 ± 730 1840 ± 980

May-June Wastewater Sampling (n=5)

  • Pharma quantifiable in hospital

wastewater and final effluent

  • Hospitals impact pharma loads in

municipal wastewater

  • Rural WWTP ineffective for pharma
  • Effluent-receiving surface water at risk

Significance of research:

 Improve understanding of pharma life cycle  Support water regulation policies in Scotland  Protect water quality in Scotland

slide-6
SLIDE 6
  • WWT Water Scotland Conference organisers and participants;
  • Supervisory team: Stuart Gibb (Director of Studies), Zulin Zhang, Mark Taggart,

Kenny Boyd;

  • Environmental Research Institute, University of the Highlands and Islands and the

James Hutton Institute;

  • Hydro Nation Scholars Programme

Acknowledgements

Thank you!!

Contact: lydia.niemi@uhi.ac.uk @LydiaNiemi

References Comber et al. 2018, Sci Tot Environ (613-514); Information Services Division, 2016, Prescription Cost Analysis; Poirier-Larabie et al. 2016, Sci Tot Environ (557-558)